GB201917863D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB201917863D0
GB201917863D0 GBGB1917863.1A GB201917863A GB201917863D0 GB 201917863 D0 GB201917863 D0 GB 201917863D0 GB 201917863 A GB201917863 A GB 201917863A GB 201917863 D0 GB201917863 D0 GB 201917863D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1917863.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Artios Pharma Ltd
Original Assignee
Artios Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Artios Pharma Ltd filed Critical Artios Pharma Ltd
Priority to GBGB1917863.1A priority Critical patent/GB201917863D0/en
Publication of GB201917863D0 publication Critical patent/GB201917863D0/en
Priority to TW109126865A priority patent/TW202120486A/en
Priority to KR1020227007755A priority patent/KR20220050148A/en
Priority to BR112022002496A priority patent/BR112022002496A2/en
Priority to AU2020327661A priority patent/AU2020327661A1/en
Priority to HUE20754011A priority patent/HUE063145T2/en
Priority to JP2022507895A priority patent/JP2022544211A/en
Priority to LTEPPCT/GB2020/051901T priority patent/LT4010329T/en
Priority to RS20230694A priority patent/RS64486B1/en
Priority to SI202030260T priority patent/SI4010329T1/en
Priority to DK20754011.3T priority patent/DK4010329T3/en
Priority to PCT/GB2020/051901 priority patent/WO2021028670A1/en
Priority to CA3149119A priority patent/CA3149119A1/en
Priority to PL20754011.3T priority patent/PL4010329T3/en
Priority to HRP20231037TT priority patent/HRP20231037T1/en
Priority to PT207540113T priority patent/PT4010329T/en
Priority to CN202080070533.0A priority patent/CN114846003A/en
Priority to EP20754011.3A priority patent/EP4010329B9/en
Priority to FIEP20754011.3T priority patent/FI4010329T3/en
Priority to US17/597,957 priority patent/US20220259174A1/en
Priority to ES20754011T priority patent/ES2952281T3/en
Priority to MX2022001690A priority patent/MX2022001690A/en
Priority to ZA2022/01364A priority patent/ZA202201364B/en
Priority to IL290415A priority patent/IL290415A/en
Ceased legal-status Critical Current

Links

GBGB1917863.1A 2019-08-09 2019-12-06 Novel compounds Ceased GB201917863D0 (en)

Priority Applications (24)

Application Number Priority Date Filing Date Title
GBGB1917863.1A GB201917863D0 (en) 2019-12-06 2019-12-06 Novel compounds
TW109126865A TW202120486A (en) 2019-08-09 2020-08-07 Novel compounds
MX2022001690A MX2022001690A (en) 2019-08-09 2020-08-10 Deuterated compounds for use in the treatment of cancer.
DK20754011.3T DK4010329T3 (en) 2019-08-09 2020-08-10 DEUTERATED COMPOUNDS FOR USE IN THE TREATMENT OF CANCER
PL20754011.3T PL4010329T3 (en) 2019-08-09 2020-08-10 Deuterated compounds for use in the treatment of cancer
AU2020327661A AU2020327661A1 (en) 2019-08-09 2020-08-10 Deuterated compounds for use in the treatment of cancer
HUE20754011A HUE063145T2 (en) 2019-08-09 2020-08-10 Deuterated compounds for use in the treatment of cancer
JP2022507895A JP2022544211A (en) 2019-08-09 2020-08-10 Deuterated compound for use in treating cancer
LTEPPCT/GB2020/051901T LT4010329T (en) 2019-08-09 2020-08-10 Deuterated compounds for use in the treatment of cancer
RS20230694A RS64486B1 (en) 2019-08-09 2020-08-10 Deuterated compounds for use in the treatment of cancer
SI202030260T SI4010329T1 (en) 2019-08-09 2020-08-10 Deuterated compounds for use in the treatment of cancer
KR1020227007755A KR20220050148A (en) 2019-08-09 2020-08-10 Deuterated Compounds for Use in Cancer Treatment
PCT/GB2020/051901 WO2021028670A1 (en) 2019-08-09 2020-08-10 Deuterated compounds for use in the treatment of cancer
CA3149119A CA3149119A1 (en) 2019-08-09 2020-08-10 Deuterated compounds for use in the treatment of cancer
BR112022002496A BR112022002496A2 (en) 2019-08-09 2020-08-10 Deuterated compounds for use in the treatment of cancer
HRP20231037TT HRP20231037T1 (en) 2019-08-09 2020-08-10 Deuterated compounds for use in the treatment of cancer
PT207540113T PT4010329T (en) 2019-08-09 2020-08-10 Deuterated compounds for use in the treatment of cancer
CN202080070533.0A CN114846003A (en) 2019-08-09 2020-08-10 Deuterated compounds for the treatment of cancer
EP20754011.3A EP4010329B9 (en) 2019-08-09 2020-08-10 Deuterated compounds for use in the treatment of cancer
FIEP20754011.3T FI4010329T3 (en) 2019-08-09 2020-08-10 Deuterated compounds for use in the treatment of cancer
US17/597,957 US20220259174A1 (en) 2019-08-09 2020-08-10 Deuterated compounds for use in the treatment of cancer
ES20754011T ES2952281T3 (en) 2019-08-09 2020-08-10 Deuterated compounds for use in cancer treatment
ZA2022/01364A ZA202201364B (en) 2019-08-09 2022-01-28 Deuterated compounds for use in the treatment of cancer
IL290415A IL290415A (en) 2019-08-09 2022-02-07 Deuterated compounds for use in the treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1917863.1A GB201917863D0 (en) 2019-12-06 2019-12-06 Novel compounds

Publications (1)

Publication Number Publication Date
GB201917863D0 true GB201917863D0 (en) 2020-01-22

Family

ID=69171831

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1917863.1A Ceased GB201917863D0 (en) 2019-08-09 2019-12-06 Novel compounds

Country Status (1)

Country Link
GB (1) GB201917863D0 (en)

Similar Documents

Publication Publication Date Title
GB201902327D0 (en) Novel compounds
GB201912674D0 (en) Novel compounds
GB201905375D0 (en) Novel compounds
GB201905371D0 (en) Novel compounds
GB201905721D0 (en) Compounds
GB201918587D0 (en) Novel compounds
IL289627A (en) Novel pfar-inhibiting compounds
GB201910305D0 (en) Compounds
GB201913548D0 (en) Novel compounds
GB201908536D0 (en) Compounds
GB201908171D0 (en) Compounds
GB201910304D0 (en) Compounds
GB201908095D0 (en) Carboxy-MIDA-boronate compounds
GB201918076D0 (en) Novel compounds
GB201917863D0 (en) Novel compounds
GB201917320D0 (en) Novel compounds
GB201915129D0 (en) Novel compounds
GB201914624D0 (en) Novel compounds
GB201914623D0 (en) Novel compounds
GB201912836D0 (en) Novel compounds
GB201912865D0 (en) Novel compounds
GB201911960D0 (en) Novel compounds
GB201911777D0 (en) Novel compounds
GB201911781D0 (en) Novel compounds
GB201911717D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)